HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,471 | +57.6% | 14,050 | +77.4% | 0.00% | – |
Q2 2023 | $9,185 | +70553.8% | 7,918 | -1.6% | 0.00% | – |
Q1 2023 | $13 | +8.3% | 8,048 | +67.4% | 0.00% | – |
Q4 2022 | $12 | -100.0% | 4,809 | -93.2% | 0.00% | -100.0% |
Q3 2022 | $301,000 | +178.7% | 71,170 | +84.3% | 0.01% | +150.0% |
Q2 2022 | $108,000 | -30.3% | 38,620 | +43.0% | 0.00% | +100.0% |
Q1 2022 | $155,000 | -35.1% | 26,999 | +3.1% | 0.00% | -75.0% |
Q4 2021 | $239,000 | -51.4% | 26,186 | -43.1% | 0.00% | -69.2% |
Q3 2021 | $492,000 | +693.5% | 45,993 | +1054.2% | 0.01% | +550.0% |
Q2 2021 | $62,000 | -83.1% | 3,985 | -82.4% | 0.00% | -66.7% |
Q1 2021 | $367,000 | +697.8% | 22,619 | +929.5% | 0.01% | +500.0% |
Q4 2020 | $46,000 | -32.4% | 2,197 | -52.2% | 0.00% | 0.0% |
Q3 2020 | $68,000 | -53.4% | 4,598 | -53.4% | 0.00% | -83.3% |
Q2 2020 | $146,000 | +35.2% | 9,867 | +114.8% | 0.01% | -33.3% |
Q4 2019 | $108,000 | +8.0% | 4,593 | -15.3% | 0.01% | +28.6% |
Q3 2019 | $100,000 | +9900.0% | 5,423 | +13457.5% | 0.01% | – |
Q4 2018 | $1,000 | -87.5% | 40 | -85.1% | 0.00% | -100.0% |
Q3 2018 | $8,000 | -94.7% | 268 | -93.1% | 0.00% | -88.9% |
Q2 2018 | $152,000 | -5.0% | 3,902 | -33.0% | 0.01% | -35.7% |
Q1 2018 | $160,000 | +7900.0% | 5,826 | +5668.3% | 0.01% | – |
Q4 2017 | $2,000 | -97.8% | 101 | -98.2% | 0.00% | -100.0% |
Q3 2017 | $89,000 | – | 5,504 | – | 0.01% | – |
Q2 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q1 2017 | $3,000 | +200.0% | 200 | +150.0% | 0.00% | – |
Q4 2016 | $1,000 | -83.3% | 80 | -76.6% | 0.00% | -100.0% |
Q3 2016 | $6,000 | -75.0% | 342 | -74.6% | 0.00% | -50.0% |
Q2 2016 | $24,000 | +166.7% | 1,344 | +168.8% | 0.00% | +100.0% |
Q1 2016 | $9,000 | +800.0% | 500 | +843.4% | 0.00% | – |
Q4 2015 | $1,000 | -96.3% | 53 | -94.0% | 0.00% | -100.0% |
Q2 2015 | $27,000 | -6.9% | 880 | -56.3% | 0.00% | -50.0% |
Q1 2015 | $29,000 | +81.2% | 2,016 | +25.2% | 0.00% | +100.0% |
Q4 2014 | $16,000 | – | 1,610 | +8844.4% | 0.00% | – |
Q3 2014 | $0 | -100.0% | 18 | -99.7% | 0.00% | -100.0% |
Q2 2014 | $64,000 | +300.0% | 5,151 | +358.7% | 0.01% | +300.0% |
Q1 2014 | $16,000 | – | 1,123 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |